Christmas Disease Treatment
Treatment for hemophilia B includes intravenous infusions of factor 9 and fresh frozen plasma. Other treatments include the administration of epsilon aminocaproic acid, and coagulation factor VIIa.
Treatment of hemophilia B includes:
- Factor IX for hemophilia B
- Coagulation Factor VIIa (Recombinant)
- Fresh frozen plasma for hemophilia B
- Gene therapy for hemophilia B:
- An experimental treatment that involves introducing genetic material (DNA or RNA) into a person's cells to fight disease.
Christmas Disease Questions For Doctor
The following are some important questions to ask before and after the treatment of hemophilia B.
Questions to ask before treatment:
- What are my treatment options?
- What are the risks associated with treatment?
- Do I need to stay in the hospital?
- How long will I be in the hospital?
- What are the complications I should watch for?
- How long will I be on medication?
- What are the potential side effects of my medication?
- Does my medication interact with nonprescription medicines or supplements?
- Should I take my medication with food?
Questions to ask after treatment:
- Do I need to change my diet?
- Do I need to lose weight?
- Are there any medications or supplements I should avoid?
- When can I resume my normal activities?
- When can I return to work?
- Do I need a special exercise program?
- Will I need physical therapy?
- Will I need occupational therapy?
- What else can I do to reduce my risk for complications?
- What else can I do to reduce my risk for having this problem again?
- How often will I need to see my doctor for checkups?
- What local support and other resources are available?
Christmas Disease Specialist
Continue to Christmas Disease Home Care
- Dunn AL, Abshire TC. Recent advances in the management of the child who has hemophilia. Hematol Oncol Clin North Am. 2004 Dec;18(6):1249-76, viii. 
- Ettingshausen CE, Kreuz W. Long-term aspects of hemophilia B treatment: part I-role for prophylaxis. Blood Coagul Fibrinolysis. 2004 Jun;15 Suppl 2:S11-3. 
- Gringeri A. Long-term aspects of hemophilia B treatment: part II. Blood Coagul Fibrinolysis. 2004 Jun;15 Suppl 2:S15-6. 
- Leissinger CA. Prevention of bleeds in hemophilia patients with inhibitors: emerging data and clinical direction. Am J Hematol. 2004 Oct;77(2):187-93. 
- Plug I, van der Bom JG, Peters M, et al. Thirty years of hemophilia treatment in the Netherlands, 1972-2001. Blood. 2004 Dec 1;104(12):3494-500.